|
Ihle, Nathan T; Williams, Ryan; Chow, Sherry et al. (2004) Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling. Mol Cancer Ther 3:763-72
|
|
Meuillet, Emmanuelle J; Mahadevan, Daruka; Vankayalapati, Hariprasad et al. (2003) Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues. Mol Cancer Ther 2:389-99
|
|
Husbeck, B; Berggren, M I; Powis, G (2001) DNA microarray reveals increased expression of thioredoxin peroxidase in thioredoxin-1 transfected cells and its functional consequences. Adv Exp Med Biol 500:157-68
|
|
Powis, G; Montfort, W R (2001) Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 30:421-55
|
|
Kakolyris, S; Giatromanolaki, A; Koukourakis, M et al. (2001) Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res 7:3087-91
|
|
Powis, G; Montfort, W R (2001) Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 41:261-95
|
|
Berggren, M M; Powis, G (2001) Alternative splicing is associated with decreased expression of the redox proto-oncogene thioredoxin-1 in human cancers. Arch Biochem Biophys 389:144-9
|
|
Berggren, M I; Husbeck, B; Samulitis, B et al. (2001) Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys 392:103-9
|
|
Engman, L; Kandra, T; Gallegos, A et al. (2000) Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Anticancer Drug Des 15:323-30
|
|
Powis, G; Mustacich, D; Coon, A (2000) The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29:312-22
|
Showing the most recent 10 out of 44 publications
